KRYS
Krystal Biotech, Inc.
NASDAQ · USHealthcareBiotechnology
$339.22-4.41%
Price as of Jul 20, 2026
KRYS valuation
Krystal Biotech, Inc. valuation
Trailing, forward and enterprise-value multiples for the requested listing.
Forward multiples
- P/E forward
- 34.91x
- P/E 2026E
- 44.95x
- P/E 2027E
- 34.10x
- P/E 2028E
- 25.57x
- P/S forward
- 15.71x
Trailing multiples
- P/E TTM
- 43.77x
- PEG TTM
- 1.75x
- Price / book
- 7.83x
- Price / sales
- 23.96x
- Price / cash flow
- 39.96x
Enterprise value
- Enterprise value
- $9.2B
- EV / sales
- 22.01x
- EV / EBITDA
- 45.78x
- EV / EBIT
- 51.37x
- Market cap
- $10.0B
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.